Header

Search

Zurich Hub for Drug and Device Development (ZH3D)

We translate research excellence into impact.

As a center of excellence, we enable researchers in Zurich to translate biomedical research findings into clinical applications more quickly, effectively, and with quality assurance, with the aim of improving the health of humans and animals.

We promote biomedical innovation by providing a state-of-the-art, quality-controlled, and regulated research and development environ ment. As an interdisciplinary platform based in Zurich, we operate at the intersection of research, medicine, and industry. We bridge the gap between research and clinical application by translating excellent sci ence into practice in accordance with regulatory requirements and by fostering the sustainable transfer of knowledge.

Are you interested in an exchange or collaboration with ZH3D?
Dr. Ralph Schiess, Founding CEO, looks forward to hearing from you.

Values

Our values are the fuel that drives us to transform research into tangible impact. They reflect who we are and how we work – bold, precise, and always with an eye on the future.

Grid containing content elements

Unique Selling Propositions

ZH3D brings together specialized expertise at UZH on regulatory requirements and quality standards for the development and approval of drugs and medical devices. Together with our partners, we support researchers in effectively translating biomedical innovations into clinical development and application.

Additional Information

Regulatory Expertise

Expertise in regulatory requirements and quality standards for drugs and medical devices.

 

 

Quality Standards Expertise

Specialization in ISO, GxP, and industry-specific standards to ensure the highest quality.


 

Bridge Between Research and Practice

Translating biomedical research findings into concrete clinical applications.

 

 

Collaborative Approach

Close collaboration with partners to ensure efficient and safe translation.

Patient-Centered Solutions

Focus on innovations that directly benefit patients.